MarketCap
Facebook
X
Telegram
Vivos Therapeutics Interest Expense | VVOS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 M | -110 K | -212 K | -190 K | 14 K | 96 K | 138 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 M | -212 K | 162 K |
Quarterly Interest Expense Vivos Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 M | 500 K | -163 K | -4 K | - | -18 K | -22 K | -1 K | - | -53 K | -225 K | 51 K | - | -36 K | -37 K | - | - | 9.49 K | 251 | 82 | - | 17 K | 18.1 K | 43.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 M | -225 K | 65.6 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sintx Technologies
SINT
|
31 K | $ 1.74 | 6.75 % | $ 4.83 M |  USA |
 |
Smith & Nephew plc
SNN
|
140 M | $ 27.87 | 0.16 % | $ 24.2 B |  Britain |
 |
Tandem Diabetes Care
TNDM
|
-13 M | $ 19.88 | 0.4 % | $ 1.35 B | USA |
 |
Sensus Healthcare
SRTS
|
683 K | $ 3.16 | 0.94 % | $ 51.6 M | USA |
 |
Viemed Healthcare
VMD
|
252 K | $ 8.79 | 0.78 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
-4.4 M | $ 18.49 | 0.03 % | $ 765 M | USA |
 |
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | USA |
 |
TELA Bio
TELA
|
1.29 M | $ 0.83 | 1.05 % | $ 39 M | USA |
 |
Beyond Air
XAIR
|
-14 K | $ 3.38 | 0.93 % | $ 28.1 B | USA |
 |
Zimmer Biomet Holdings
ZBH
|
25.5 M | $ 94.22 | 0.69 % | $ 18.7 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-3.76 M | $ 8.23 | 0.71 % | $ 600 M |  Israel |
 |
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Inari Medical
NARI
|
196 K | - | - | $ 4.23 B | USA |
 |
Nemaura Medical
NMRD
|
-6.41 M | - | -17.8 % | $ 2.74 M | Britain |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
SmileDirectClub
SDC
|
1.58 M | - | -53.45 % | $ 9.71 M | USA |
 |
Sientra
SIEN
|
9.11 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
6.87 M | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
1.01 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
6.9 M | - | - | $ 12.3 B | USA |
 |
ThermoGenesis Holdings
THMO
|
10 M | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
4.81 M | - | 3.55 % | $ 7.96 M | USA |
 |
Viveve Medical
VIVE
|
1 M | - | -15.35 % | $ 1.71 M | USA |
 |
ViewRay
VRAY
|
5.06 M | - | 1.54 % | $ 468 M | USA |
 |
Titan Medical
TMDI
|
1.09 M | - | -26.32 % | $ 19.6 M | Canada |
 |
Natus Medical Incorporated
NTUS
|
1.87 M | - | 1.94 % | $ 1.05 B | USA |
 |
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | USA |
 |
Profound Medical Corp.
PROF
|
146 K | $ 6.81 | 1.32 % | $ 206 M | Canada |
 |
Abbott Laboratories
ABT
|
548 M | $ 105.52 | 0.03 % | $ 184 B | USA |
 |
Aethlon Medical
AEMD
|
10.1 K | $ 1.81 | 1.09 % | $ 1.22 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 6.19 | 1.09 % | $ 837 M | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 153.49 | 0.03 % | $ 11.1 B | USA |
 |
Apyx Medical Corporation
APYX
|
-161 K | $ 3.05 | 0.33 % | $ 125 M | USA |
 |
Accuray Incorporated
ARAY
|
5.01 M | $ 0.26 | 0.37 % | $ 31.9 M | USA |
 |
Alphatec Holdings
ATEC
|
45.9 M | $ 9.19 | 1.29 % | $ 1.38 B | USA |
 |
AxoGen
AXGN
|
167 K | $ 46.69 | 2.51 % | $ 2.15 B | USA |
 |
Butterfly Network
BFLY
|
2.77 M | $ 7.52 | 2.17 % | $ 1.86 B | USA |